Chinese Herbal Medicines最新文献

{"title":"Metabolomics combined with network pharmacology reveals anti-asthmatic effects of Nepeta bracteata on allergic asthma rats","authors":"Kailibinuer Abulaiti ,&nbsp;Miheleayi Aikepa ,&nbsp;Mireguli Ainaidu ,&nbsp;Jiaxin Wang ,&nbsp;Maiwulanijiang Yizibula ,&nbsp;Maihesumu Aikemu","doi":"10.1016/j.chmed.2024.02.001","DOIUrl":"10.1016/j.chmed.2024.02.001","url":null,"abstract":"<div><h3>Objective</h3><div>To investigate the mechanisms that underlie the anti-asthmatic effects of <em>Nepeta bracteata</em> (DBJJ, Dabao Jingjie in Chinese) in rats by integrating metabolomics and network pharmacology.</div></div><div><h3>Methods</h3><div>In this study, the rat model of asthma was induced by ovalbumin (OVA), and the rats were treated with a decoction of <em>N. bracteata</em>. Pathological changes in lung tissue were observed, and the quantification of eosinophils (EOS) and white blood cells (WBC) in bronchoalveolar lavage fluid was performed. Furthermore, the serum levels of asthma-related factors induced by OVA were assessed. ¹H NMR spectroscopy serum metabolomics method was utilized to identify differential metabolites and their associated metabolic pathways. UPLC-QE-MS/MS combined with network pharmacology was employed to predict the core targets and pathways of DBJJ in its action against asthma. The anti-asthmatic properties of DBJJ were investigated using an integrated approach of metabolomics and network pharmacology. The findings were validated through molecular docking and Western blotting analysis of the key targets.</div></div><div><h3>Results</h3><div>The administration of DBJJ effectively alleviated OVA-induced lung histopathological changes and decreased the number of EOS and WBC in BALF. Additionally, DBJJ inhibited the OVA-induced elevation of TNF-α, IL-18, Ig-E, EOS, IL-1β, MDA, VEGF-A, and TGF-β1. A total of 21 biomarkers and 10 pathways were found by metabolomics analysis. A total of 29 compounds were identified by UPLC-QE-MS/MS, in which 13 active components were screened by oral availability and Caco-2 cell permeability, the 120 targets and 173 KEGG pathways were predicted. The integration of metabolomics and network pharmacological analysis revealed that DBJJ's main constituents, including ferulic acid and ursolic acid, exerted their effects on four targets, namely DAO and NOS2, as well as their associated metabolites and pathways. The active constituents of DBJJ demonstrated a high binding affinity towards DAO and NOS2. Furthermore, DBJJ was observed to decrease the protein expression and phosphorylation levels of NOS2, MAPK, and STAT3.</div></div><div><h3>Conclusion</h3><div>The administration of DBJJ demonstrates notable anti-asthma properties in rats with allergic asthma. This effect can be attributed to the modulation of various targets, including NOS2, MAPK, and STAT3, by primary constituents such as ferulic acid and ursolic acid.</div></div>","PeriodicalId":9916,"journal":{"name":"Chinese Herbal Medicines","volume":"16 4","pages":"Pages 599-611"},"PeriodicalIF":4.7,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140402265","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Mechanisms of Shufeng Jiedu Capsule in treating bacterial pneumonia based on network pharmacology and experimental verification","authors":"Yingli Xu ,&nbsp;Lei Bao ,&nbsp;Ronghua Zhao,&nbsp;Zihan Geng,&nbsp;Shuran Li,&nbsp;Bo Pang,&nbsp;Qiyue Sun,&nbsp;Shanshan Guo,&nbsp;Xiaolan Cui,&nbsp;Jing Sun","doi":"10.1016/j.chmed.2024.01.002","DOIUrl":"10.1016/j.chmed.2024.01.002","url":null,"abstract":"<div><h3>Objective</h3><div>The aim of this study was to investigate the underlying mechanism of Shufeng Jiedu Capsule (SFJD) for treating bacterial pneumonia (BP) <em>in vivo</em> based on network pharmacology and experimental verification study.</div></div><div><h3>Methods</h3><div>Network pharmacology was used to screen the active compounds and target genes of SFJD. Then, the multi drug resistance-<em>Pseudomonas aeruginosa</em> (MDR-PA) mice lethal model and MDR-PA pneumonia model were established to evaluate the therapeutic effects and underlying mechanisms of SFJD. Western blot and ELISA were used to determinate the protein expression level of the IL-17 signaling pathway and JAK/STAT signaling pathway.</div></div><div><h3>Results</h3><div>After screening, 172 potential components of SFJD were generated, based on which we constructed an SFJD-component-target-BP interaction network. The Gene ontology (GO) and Kyoto encyclopedia of genes and genomes (KEGG) enrichment revealed that SFJD could regulate the IL-17 signaling pathway and Janus kinase/signal transducer and activator of transcription (JAK/STAT) signaling pathway. Molecular docking showed that the potential target proteins had good combinations with the main active components. SFJD significantly reduced the mortality and prolonged survival days in lethal models. The lung index and pathological changes in the lung were also significantly decreased. SFJD could significantly decrease the expression of interleukin-17A (IL-17A), TNF receptor associated factor 6 (TRAF6), phospho-inhibitor of nuclear factor-kappa B (p-IκB)/inhibitor of NF-κB (IκB), phospho-NF-κB p65 (p-NF-κB p65), phospho-protein kinase B (p-AKT)/AKT, phospho-signal transducer and activator of transcription 3 (p-STAT3)/STAT3, phospho-signal transducer and activator of transcription 1 (p-STAT1)/STAT1, and the protein level of interleukin-6 (IL-6), tumor necrosis factor α (TNF-α), and IL-1β.</div></div><div><h3>Conclusion</h3><div>Combined with network pharmacology and <em>in vivo</em> study, it was found that SFJD exerted its therapeutic effects on BP by inhibiting the IL-17 pathway and JAK/STAT signaling pathway. This study provides new evidence for SFJD in treatment of BP.</div></div>","PeriodicalId":9916,"journal":{"name":"Chinese Herbal Medicines","volume":"16 4","pages":"Pages 656-666"},"PeriodicalIF":4.7,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140402281","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Network pharmacology, molecular docking, and untargeted metabolomics reveal molecular mechanisms of multi-targets effects of Qingfei Tongluo Plaster improving respiratory syncytial virus pneumonia","authors":"Mengfei Yang ,&nbsp;Xiuying Zhang ,&nbsp;Qing Liu ,&nbsp;Yongxue Wang","doi":"10.1016/j.chmed.2024.07.007","DOIUrl":"10.1016/j.chmed.2024.07.007","url":null,"abstract":"&lt;div&gt;&lt;h3&gt;Objective&lt;/h3&gt;&lt;div&gt;Qingfei Tongluo Plaster (QFP), an improved Chinese medicine hospital preparation, is an attractive treatment option due to its well clinical efficacy, convenience, economy, and patient compliance in the treatment of respiratory syncytial virus (RSV) pneumonia. The aim of this study was to investigate the efficacy mechanism of QFP on RSV rats from the perspective of alleviating lung inflammation and further explore the changes of serum metabolites and metabolic pathways in RSV rats under the influence of QFP.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Methods&lt;/h3&gt;&lt;div&gt;This study used network pharmacological methods and molecular docking combined with molecular biology and metabolomics from multi-dimensional perspectives to screen and verify the therapeutic targets. Open online databases were used to speculate the gene targets of efficient ingredients and diseases. Then, we used the String database to examine the fundamental interaction of common targets of drugs and diseases. An online enrichment analysis was performed to predict the functional pathways. Molecular docking was applied to discover the binding modes between essential ingredients and crucial gene targets. Finally, we demonstrated the anti-inflammatory ability of QFP in the RSV-evoked pneumonia rat model and explained the mechanism in combination with the metabolomics results.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Results&lt;/h3&gt;&lt;div&gt;There were 19 critical targets defined as the core targets: tumor necrosis factor (&lt;em&gt;TNF&lt;/em&gt;), inducible nitric oxide synthase 2 (&lt;em&gt;NOS2&lt;/em&gt;), mitogen-activated protein kinase 14 (&lt;em&gt;MAPK14&lt;/em&gt;), g1/S-specific cyclin-D1 (&lt;em&gt;CCND1&lt;/em&gt;), signal transducer and activator of transcription 1-alpha/beta (&lt;em&gt;STAT1&lt;/em&gt;), proto-oncogene tyrosine-protein kinase Src (&lt;em&gt;SRC&lt;/em&gt;), cellular tumor antigen p53 (&lt;em&gt;TP53&lt;/em&gt;), interleukin-6 (&lt;em&gt;IL6&lt;/em&gt;), hypoxia-inducible factor 1-alpha (&lt;em&gt;HIF1A&lt;/em&gt;), RAC-alpha serine/threonine-protein kinase (&lt;em&gt;AKT1&lt;/em&gt;), signal transducer and activator of transcription 3 (&lt;em&gt;STAT3&lt;/em&gt;), heat shock protein HSP 90-alpha (&lt;em&gt;HSP90AA1&lt;/em&gt;), tyrosine-protein kinase JAK2 (&lt;em&gt;JAK2&lt;/em&gt;), cyclin-dependent kinase inhibitor 1 (&lt;em&gt;CDKN1A&lt;/em&gt;), mitogen-activated protein kinase 3 (&lt;em&gt;MAPK3&lt;/em&gt;), epidermal growth factor receptor (&lt;em&gt;EGFR&lt;/em&gt;), myc proto-oncogene protein (&lt;em&gt;MYC&lt;/em&gt;), protein c-Fos (&lt;em&gt;FOS&lt;/em&gt;) and transcription factor p65 (&lt;em&gt;RELA&lt;/em&gt;). QFP treated RSV pneumonia mainly through the phosphatidylinositol 3-kinase (PI3K)/RAC AKT pathway, HIF-1 pathway, IL-17 pathway, TNF pathway, and MAPK pathway. Animal experiments proved that QFP could effectively ameliorate RSV-induced pulmonary inflammation. A total of 28 metabolites underwent significant changes in the QFP treatment, and there are four metabolic pathways consistent with the KEGG pathway analyzed by network pharmacology, suggesting that they may be critical processes related to treatment.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Conclusion&lt;/h3&gt;&lt;div&gt;These results provide essential p","PeriodicalId":9916,"journal":{"name":"Chinese Herbal Medicines","volume":"16 4","pages":"Pages 638-655"},"PeriodicalIF":4.7,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142651770","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Phytochemistry, quality control and biosynthesis in ginseng research from 2021 to 2023: A state-of-the-art review concerning advances and challenges","authors":"Mengxiang Ding ,&nbsp;Huizhen Cheng ,&nbsp;Xiaohang Li ,&nbsp;Xue Li,&nbsp;Min Zhang,&nbsp;Dianxin Cui,&nbsp;Yijin Yang,&nbsp;Xiaojin Tian,&nbsp;Hongda Wang,&nbsp;Wenzhi Yang","doi":"10.1016/j.chmed.2024.08.002","DOIUrl":"10.1016/j.chmed.2024.08.002","url":null,"abstract":"<div><div><em>Panax</em> L. (Araliaceae) has a long history of medicinal and edible use due to its significant tonifying effects, and ginseng research has been a hot topic in natural products research and food science. In continuation of our recent ginseng review, we highlighted the advances in ginseng research from 2021 to 2023 with 157 citations, which exhibited the increasingly systematic, collaborative, and intelligent characteristics. In this review, we firstly updated the progress in phytochemistry involving the ginsenosides and polysaccharides and summarized the researches on the active components. Then, some specific applications by feat of the multidimensional chromatography, mass spectrometry imaging, DNA barcoding, and metabolomics, were analyzed, which could provide rich information supporting the multi-component characterization, authentication, and quality control of ginseng and the versatile products. Finally, the recent biosynthesis studies concerning ginsenosides were retrospected. Additionally, the current challenges and future trends with respect to ginseng research were discussed.</div></div>","PeriodicalId":9916,"journal":{"name":"Chinese Herbal Medicines","volume":"16 4","pages":"Pages 505-520"},"PeriodicalIF":4.7,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142651773","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Compound Danshen Dripping Pills combined with isosorbide mononitrate for angina pectoris: A systematic review and a Meta-analysis","authors":"Ru Wang,&nbsp;Jing Hu,&nbsp;Yuanyuan Li,&nbsp;Hong Yin","doi":"10.1016/j.chmed.2023.12.005","DOIUrl":"10.1016/j.chmed.2023.12.005","url":null,"abstract":"<div><h3>Objective</h3><div>To evaluate the efficacy of Compound Danshen Dripping Pills (CDDP) combined with isosorbide mononitrate (ISMN) versus ISMN alone for treating angina pectoris in patients.</div></div><div><h3>Methods</h3><div>The PubMed, Web of Science, Cochrane Library, Embase China National Knowledge Infrastructure, China Biomedical Literature Service System, Chinese Medical Journal Database, and Wan Fang MED databases were searched from inception to November 2022. Randomized controlled trials (RCTs) and cohort studies were included. The primary outcomes were angina symptom and electrocardiography (ECG) efficacy, angina symptom efficacy, and ECG efficacy. The protocol was registered with PROSPERO No. CRD42022314774.</div></div><div><h3>Results</h3><div>Our study included 7 245 patients with angina (59 RCTs, 11 cohort studies). When ISMN was combined with CDDP, the efficacy of angina symptom and ECG [odds ratio (OR) = 4.824, 95% confidence interval (CI) = 3.636–6.401, <em>P</em> = 0.000], the efficacy of angina symptom (OR = 4.347, 95% CI = 3.635–5.198, <em>P</em> = 0.000), the efficacy of ECG (OR = 3.364, 95% CI = 2.767–4.089, <em>P</em> = 0.000) were better than that of patients treated with ISMN alone. CDDP combined with ISMN was superior to ISMN alone in reducing triglyceride (TG) [mean difference (MD) =  −35.176, 95% CI =  −37.439 to −32.912, <em>P</em> = 0.000], total cholesterol (TC) (MD =  −24.296, 95% CI =  −26.429 to −22.163, <em>P</em> = 0.000), the duration of angina attack (MD =  −1.991, 95% CI =  −2.349 to −1.633, <em>P</em> = 0.000), and the frequency of angina attack [standardized MD (SMD) =  −2.840, 95% CI =  −3.416 to −2.265, <em>P</em> = 0.000]. There was no increase in adverse events between CDDP combined with ISMN and ISMN alone (OR = 0.513, 95% CI = 0.421–0.626, <em>P</em> = 0.000).</div></div><div><h3>Conclusion</h3><div>CDDP combined with ISMN improved treatment efficacy and was well tolerated. Therefore, this combination could be used as an alternative treatment. However, clinical and patient conditions should be considered.</div></div>","PeriodicalId":9916,"journal":{"name":"Chinese Herbal Medicines","volume":"16 4","pages":"Pages 622-637"},"PeriodicalIF":4.7,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140400632","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Research progress on chemical diversity of saponins in Panax ginseng","authors":"Xiaoyu Geng ,&nbsp;Jia Wang ,&nbsp;Yuwei Liu ,&nbsp;Linxuan Liu ,&nbsp;Xuekun Liu ,&nbsp;Yan Zhao ,&nbsp;Cuizhu Wang ,&nbsp;Jinping Liu","doi":"10.1016/j.chmed.2024.08.005","DOIUrl":"10.1016/j.chmed.2024.08.005","url":null,"abstract":"<div><div>Saponins, the major bioactive components of <em>Panax ginseng</em> C. A. Mey., are gradually emerging as research hotspots owing to the possession of various pharmacological activities. This review updates the ginsenosides list from <em>P. ginseng</em> and the steam-processed ginseng (red ginseng and black ginseng) up to 271 by June of 2024, encompassing 243 saponins from different parts of <em>P. ginseng</em> (roots, stems, leaves, flowers, berries, and seeds), 103 from red ginseng, and 65 from black ginseng, respectively. Among 271 saponins, there are a total of 249 (<strong>1</strong>–<strong>249</strong>) dammarane type (with <strong><em>a</em></strong>–<strong><em>z</em></strong> subtypes) tetracyclic triterpene saponins reported from each part of <em>P. ginseng</em> and steam-processed ginseng, two (<strong>250</strong>–<strong>251</strong>) lanostane type tetracyclic triterpene saponins identified from red ginseng, 18 (<strong>252</strong>–<strong>269</strong>) oleanane type pentacyclic triterpenoid saponins discovered from each part of <em>P. ginseng</em> and steam-processed ginseng, and two (<strong>270</strong>–<strong>271</strong>) ursane type pentacyclic triterpenoid saponins reported from red ginseng. Overall, this review expounds on the chemical diversity of ginsenosides in various aspects, such as chemical structure, spatial distribution and subtype comparison, processed products, and transformation. This facilitates more in-depth research on ginsenosides and contributes to the future development of ginseng.</div></div>","PeriodicalId":9916,"journal":{"name":"Chinese Herbal Medicines","volume":"16 4","pages":"Pages 529-547"},"PeriodicalIF":4.7,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142651774","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Effects of steaming process on rare saponins and efficacy of Panax ginseng, Panax notoginseng and Panax quinquefolium","authors":"Wenjie Zhao ,&nbsp;Linlin Han ,&nbsp;Tao Li,&nbsp;Jungjoon Lee,&nbsp;Yuqing Zhao","doi":"10.1016/j.chmed.2024.07.003","DOIUrl":"10.1016/j.chmed.2024.07.003","url":null,"abstract":"<div><div>The steamed <em>Panax ginseng</em> C. A. Mey., <em>Panax notoginseng</em> (Burk.) F. H. Chen, and <em>Panax quinquefolium</em> L. not only facilitate storage, but also increase the content of rare saponins and enhance their clinical application value. The traditional steaming process has high energy consumption, low efficiency, and lacks standardized operating procedures and unified standards. This paper retrieves the research literature on the steaming process parameters, rare saponin increments, and efficacy enhancement results of ginseng plants. By summarizing the effects of different steaming processes on rare saponins and pharmacodynamics in <em>P. ginseng</em>, <em>P. notoginseng</em> and <em>P. quinquefolium</em>, we explored new steaming methods and established a new quality evaluation system to provide guarantee for the effectiveness and safety of clinical medication and provide scientific basis for its rational use.</div></div>","PeriodicalId":9916,"journal":{"name":"Chinese Herbal Medicines","volume":"16 4","pages":"Pages 521-528"},"PeriodicalIF":4.7,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141839759","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Treatment of constipation with Aloe and its compatibility prescriptions","authors":"Xianhui Shen ,&nbsp;Liping Gong ,&nbsp;Rongrong Li ,&nbsp;Nana Huang ,&nbsp;Huijie Zhang ,&nbsp;Siyi Chen ,&nbsp;Ying Liu ,&nbsp;Rong Sun","doi":"10.1016/j.chmed.2024.07.005","DOIUrl":"10.1016/j.chmed.2024.07.005","url":null,"abstract":"<div><div>Constipation is a common and prevalent digestive system disease in clinical practice, which seriously affects human physical and mental health. Currently, chemical drugs have good short-term therapeutic effects. However, because of their adverse reactions, easy recurrence after drug discontinuation, and dependence with long-term use, the long-term efficacy is unsatisfactory. The pathogenesis of constipation is mainly attributed to dysfunction of zang-fu organs and imbalance of qi-blood and yin-yang, with the syndrome being asthenia in origin and asthenia in superficiality. <em>Aloe</em> is a traditional Chinese medicine with cold properties and a bitter taste, and one of the most commonly used herbs for constipation. Based on <em>Aloe</em> and its monomer components, combined with the existing compatibility studies of <em>Aloe</em> and several Chinese patent drugs represented by <em>Aloe</em>, this paper comprehensively and systematically introduced the research progress of <em>Aloe</em> and its compatibility prescriptions in the treatment of constipation from basic experiments to clinical observations, providing theoretical basis and medication guidance for the clinical rational application of <em>Aloe</em> and its prescriptions in the treatment of constipation. At the same time, it also provides the direction for future research on the mechanism of <em>Aloe</em> in the treatment of constipation.</div></div>","PeriodicalId":9916,"journal":{"name":"Chinese Herbal Medicines","volume":"16 4","pages":"Pages 561-571"},"PeriodicalIF":4.7,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141853581","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Network pharmacology for traditional Chinese medicine in era of artificial intelligence","authors":"Weibo Zhao,&nbsp;Boyang Wang,&nbsp;Shao Li","doi":"10.1016/j.chmed.2024.08.004","DOIUrl":"10.1016/j.chmed.2024.08.004","url":null,"abstract":"<div><h3>Abstract</h3><div>Traditional Chinese Medicine Network Pharmacology (TCM-NP) is an interdisciplinary discipline that integrates information science, systems biology, network science and pharmacology, providing a systematic research methodology for TCM studies. With the development of artificial intelligence (AI) and multi-omics technologies, TCM-NP has entered a new era and can incorporate multimodal and high-dimensional data in the context of big data to enhance both theoretical foundations and technical capabilities. Despite its advancement, TCM-NP still faces challenges, particularly in ensuring the quality of data and research, as well as achieving more profound scientific discoveries. The field needs further innovation to obtain more precise and biomedically meaningful results. Overall research progress in TCM-NP depends on developing more accurate algorithms together with utilizing higher-quality and larger-scale data. This paper gives a perspective on the trends and characteristics of TCM-NP development and application in the era of AI.</div></div>","PeriodicalId":9916,"journal":{"name":"Chinese Herbal Medicines","volume":"16 4","pages":"Pages 558-560"},"PeriodicalIF":4.7,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142651776","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Integrating tradition and innovation: Health industry opportunities for ginseng with foods and medicines","authors":"Wei Li","doi":"10.1016/j.chmed.2024.09.007","DOIUrl":"10.1016/j.chmed.2024.09.007","url":null,"abstract":"","PeriodicalId":9916,"journal":{"name":"Chinese Herbal Medicines","volume":"16 4","pages":"Pages 487-488"},"PeriodicalIF":4.7,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142651771","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}